Patents by Inventor Jeton Luzha

Jeton Luzha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Eukaryotic translation initiation factors (eIFs) as novel biomarkers in bladder cancer
    Patent number: 11959918
    Abstract: The present invention relates to a method of diagnosing bladder cancer in an individual. Further, the present invention relates to a method of determining the course of bladder cancer in an individual. Furthermore, the present invention relates to a kit for diagnosing bladder cancer in an individual or determining the course of bladder cancer in an individual.
    Type: Grant
    Filed: June 24, 2020
    Date of Patent: April 16, 2024
    Assignee: OTTO-VON-GUERICKE-UNIVERSITÄT MAGDEBURG
    Inventors: Johannes Haybäck, Jeton Luzha
  • EUKARYOTIC TRANSLATION INITIATION FACTORS (EIFS) AS NOVEL BIOMARKERS IN BLADDER CANCER
    Publication number: 20210025891
    Abstract: The present invention relates to a method of diagnosing bladder cancer in an individual. Further, the present invention relates to a method of determining the course of bladder cancer in an individual. Furthermore, the present invention relates to a kit for diagnosing bladder cancer in an individual or determining the course of bladder cancer in an individual.
    Type: Application
    Filed: June 24, 2020
    Publication date: January 28, 2021
    Inventors: Johannes Haybäck, Jeton Luzha